mbiomics GmbH

Germany - Munich, Bavaria

• 24/03/2023
• Series A
• $13,945,000

We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.

Related People

Laura FigullaCo Founder

Germany - Munich, Bavaria

With 15+years of life science entrepreneurial and strategy&transactions consulting experience, including venture capital, M&A, digital transformation and innovation strategy, as well as in-depth industry expertise and strong public relations skills, I am truly passionate about creating company strategies, vision and enabling high-performing teams. My career background allows me to provide strategic, fundraising, and business operations insight for innovative life sciences players, in particular around digital health and biotechnology business models.

LinkedIn https://www.linkedin.com/in/laura-figulla-523a0592/?locale=en_US